Health Canada continues to monitor newly approved drugs to determine if the benefits identified in the pre-market trials hold up to further scrutiny. Canadians need better access to that information.
Academic rigor, journalistic flair
Articles on Pharma
Displaying all articles
Preventing big firms buying up small ones can sometimes stop new products reaching consumers.
Generic drug names are often long, but they can tell doctors what type of medicine it is and how it works. But it’s brand names that appear first and most prominently in Health Canada materials.
Once a coronavirus vaccine is approved, billions of doses need to be manufactured. Current vaccine production is nowhere near ready, for a variety of reasons, but planning now could help.
India could help overcome ‘vaccine nationalism’ because it is the major supplier of medicines to the global south.
In 2016, drug misuse was cited as the top concern among New Hampshire voters. What remedies are the Democratic primary contenders putting forward to combat the opioid crisis?
American companies still face enormous uncertainty about how they’ll be doing business in the UK and EU in the coming years, particularly as the April 12 Brexit deadline draws closer.
This week’s annual Family Medicine Forum is an opportunity for your family doctor – to cave or resist in the face of Big Pharma sponsorship and marketing.
Most countries need to find a happy balance between the American attitude that all pain needs to be cured – and the ethos in other countries that pain is to be endured.
Digital health devices have become invaluable tools for improving human health. However, could a pill carrying an inbuilt sensor dehumanize patients, reducing them to a digital readout?
Top contributors
-
Joel Lexchin is a Friend of The Conversation.Professor Emeritus of Health Policy and Management, York University, Canada
-
Lecturer in Family Medicine, Faculty of Medicine, L’Université d’Ottawa/University of Ottawa
-
Regents and Distinguished Professor of Environmental and Occupational Health, Texas A&M University
-
Senior Lecturer, Global Development Institute, University of Manchester
-
Associate Professor of Science in Society, Wesleyan University
-
Clinical Associate Professor of Business Economics, Indiana University
-
Senior Lecturer in Economics, Lancaster University Management School, Lancaster University
-
Assistant Scientist, Johns Hopkins University
-
Professor of Health Policy and Management, City University of New York
-
Assistant Professor, Department of Family and Community Medicine, University of Toronto
